Drugs / Hypidone Hydrochloride
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04598607 | Oct 2020 → Jan 2021 | major depressive disorder | Zhejiang Huahai Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03404466 | Feb → Jul 2018 | major depressive disorder | Zhejiang Huahai Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hypidone Hydrochloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03404466 ↗ |
| Route | Oral | “Study drug is to be given orally” NCT03404466 ↗ |